Compare KZIA & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZIA | OMH |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | Australia | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.5M | 17.6M |
| IPO Year | 1999 | 2023 |
| Metric | KZIA | OMH |
|---|---|---|
| Price | $10.59 | $1.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 176.9K |
| Earning Date | 12-26-2025 | 04-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,199,108.00 | ★ $10,264,748.00 |
| Revenue This Year | N/A | $28.40 |
| Revenue Next Year | N/A | $23.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 78.86 |
| 52 Week Low | $2.86 | $0.59 |
| 52 Week High | $21.00 | $5.10 |
| Indicator | KZIA | OMH |
|---|---|---|
| Relative Strength Index (RSI) | 51.53 | 53.24 |
| Support Level | $11.75 | $0.79 |
| Resistance Level | $17.40 | $1.15 |
| Average True Range (ATR) | 2.71 | 0.06 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 35.08 | 65.12 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.